The pharmaceutical industry is aggressively evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, represents copyrightple of this trend. To address this demand, US-based manufacturing services are stepping forward. These companies offer a wide-ranging suite of solutions, from